{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:04:34Z","timestamp":1789203874072,"version":"build-2803163510"},"reference-count":158,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T00:00:00Z","timestamp":1674345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Perinatal asphyxia is considered to be one of the major causes of brain neurodegeneration in full-term newborns. The worst consequence of perinatal asphyxia is neurodegenerative brain damage, also known as hypoxic-ischemic encephalopathy. Hypoxic-ischemic encephalopathy is the leading cause of mortality in term newborns. To date, due to the complex mechanisms of brain damage, no effective or causal treatment has been developed that would ensure complete neuroprotection. Although hypothermia is the standard of care for hypoxic-ischemic encephalopathy, it does not affect all changes associated with encephalopathy. Therefore, there is a need to develop effective treatment strategies, namely research into new agents and therapies. In recent years, it has been pointed out that natural compounds with neuroprotective properties, such as melatonin, can be used in the treatment of hypoxic-ischemic encephalopathy. This natural substance with anti-inflammatory, antioxidant, anti-apoptotic and neurofunctional properties has been shown to have pleiotropic prophylactic or therapeutic effects, mainly against experimental brain neurodegeneration in hypoxic-ischemic neonates. Melatonin is a natural neuroprotective hormone, which makes it promising for the treatment of neurodegeneration after asphyxia. It is supposed that melatonin alone or in combination with hypothermia may improve neurological outcomes in infants with hypoxic-ischemic encephalopathy. Melatonin has been shown to be effective in the last 20 years of research, mainly in animals with perinatal asphyxia but, so far, no clinical trials have been performed on a sufficient number of newborns. In this review, we summarize the advantages and limitations of melatonin research in the treatment of experimental and clinical perinatal asphyxia.<\/jats:p>","DOI":"10.3390\/molecules28031105","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T01:36:26Z","timestamp":1674437786000},"page":"1105","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Melatonin: A Potential Candidate for the Treatment of Experimental and Clinical Perinatal Asphyxia"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-1356","authenticated-orcid":false,"given":"Ryszard","family":"Pluta","sequence":"first","affiliation":[{"name":"Ecotech-Complex Analytical and Programme Centre for Advanced Environmentally-Friendly Technologies, Marie Curie-Sk\u0142odowska University in Lublin, 20-612 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Furmaga-Jab\u0142o\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Neonate and Infant Pathology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Januszewski","sequence":"additional","affiliation":[{"name":"Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-4213","authenticated-orcid":false,"given":"Agata","family":"Tarkowska","sequence":"additional","affiliation":[{"name":"Department of Neonate and Infant Pathology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,22]]},"reference":[{"key":"ref_1","first-page":"1985","article-title":"Neonatal brain injury","volume":"352","author":"Kruszewski","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1469-8749.1992.tb11432.x","article-title":"Relation between cerebral oxidative metabolism following birth asphyxia, and neurodevelopmental outcome and brain growth at one year","volume":"34","author":"Roth","year":"1992","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1467-7687.2006.00499.x","article-title":"Brain and cognitive-behavioural development after asphyxia at term birth","volume":"9","author":"Wyatt","year":"2006","journal-title":"Dev. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/siny.2001.0042","article-title":"Hypoxic-ischemic brain injury in the newborn: Pathophysiology and potential strategies for intervention","volume":"6","author":"Gluckman","year":"2001","journal-title":"Semin. Neonatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e12479","DOI":"10.1111\/jpi.12479","article-title":"Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs","volume":"64","author":"Aridas","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum. Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(05)71048-5","article-title":"4 million neonatal deaths: When? Where? Why?","volume":"365","author":"Lawn","year":"2005","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/08830738010160110201","article-title":"Long-term developmental outcome of asphyxiated term neonates","volume":"16","author":"Dilenge","year":"2001","journal-title":"J. Child Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ajog.2008.06.094","article-title":"A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy","volume":"199","author":"Graham","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mohsenpour, H., Pesce, M., Patruno, A., Bahrami, A., Pour, P.M., and Farzaei, M.H. (2021). A review of plant extracts and plant-derived natural compounds in the prevention\/treatment of neonatal hypoxic-ischemic brain injury. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020833"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Xu, L.X., Lv, Y., Li, Y.H., Ding, X., Wang, Y., Han, X., Liu, M.H., Sun, B., and Feng, X. (2017). Melatonin alleviates brain and peripheral tissue edema in a neonatal rat model of hypoxic-ischemic brain damage: The involvement of edema related proteins. BMC Pediatr., 17.","DOI":"10.1186\/s12887-017-0824-x"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","article-title":"Childhood outcomes after hypothermia for neonatal encephalopathy","volume":"366","author":"Shankarana","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"748150","DOI":"10.3389\/fneur.2021.748150","article-title":"Therapeutic hypothermia modulates the relationships between indicators of severity of neonatal hypoxic ischemic encephalopathy and serum biomarkers","volume":"12","author":"Miller","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(05)17946-X","article-title":"Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial","volume":"365","author":"Gluckman","year":"2005","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1315788","article-title":"Effects of Hypothermia for Perinatal Asphyxia on Childhood Outcomes","volume":"371","author":"Azzopardi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpeds.2017.08.031","article-title":"Neuroprotective strategies in neonatal brain injury","volume":"192","author":"Parikh","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e12782","DOI":"10.1111\/jpi.12782","article-title":"Safety of higher doses of melatonin in adults: A systematic review and meta-analysis","volume":"72","author":"Phillips","year":"2022","journal-title":"J. Pineal Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Minich, D.M., Henning, M., Darley, C., Fahoum, M., Schuler, C.B., and Frame, J. (2022). Is melatonin the \u201cNext Vitamin D\u201d?: A review of emerging science, clinical uses, safety, and dietary supplements. Nutrients, 14.","DOI":"10.3390\/nu14193934"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.10.402","article-title":"The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health","volume":"130","author":"Luo","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fendo.2019.00249","article-title":"Melatonin synthesis and function: Evolutionary history in animals and plants","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hagstr\u00f6m, A., Kal Omar, R., Williams, P.A., and St\u00e5lhammar, G. (2022). The rationale for treating uveal melanoma with adjuvant melatonin: A review of the literature. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09464-w"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e12565","DOI":"10.1111\/jpi.12565","article-title":"Melatonin pharmaco-kinetics and dose extrapolation after enteral infusion inneonates subjected to hypothermia","volume":"66","author":"Balduini","year":"2019","journal-title":"J. Pineal Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e12818","DOI":"10.1111\/jpi.12818","article-title":"Human-rat integrated microRNAs profiling identified a new neonatal cerebral hypoxic-ischemic pathway melatonin-sensitive","volume":"73","author":"Weiss","year":"2022","journal-title":"J. Pineal Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-019-0330-8","article-title":"Pineal gland dysfunction in Alzheimer\u2019s disease: Relationship with the immune-pineal axis, sleep disturbance, and neurogenesis","volume":"14","author":"Song","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-079X.2007.00503.x","article-title":"Melatonin protects from the long-term consequences of a neonatal hypoxic\u2013ischemic brain injury in rats","volume":"44","author":"Carloni","year":"2008","journal-title":"J. Pineal Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2014.186","article-title":"Melatonin use for neuroprotection in perinatal asphyxia: A randomized controlled pilot study","volume":"35","author":"Aly","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6308255","DOI":"10.1155\/2021\/6308255","article-title":"Antioxidant effect of melatonin in preterm newborns","volume":"2021","author":"Marseglia","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"585898","DOI":"10.3389\/fphar.2020.585898","article-title":"Lycopene exerts neuroprotective effects after hypoxic-ischemic brain injury in neonatal rats via the nuclear factor erythroid-2 related factor 2\/nuclear factor-\u03ba-gene binding pathway","volume":"11","author":"Fu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/NEN.0000000000000056","article-title":"Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia","volume":"73","author":"Schiering","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_30","first-page":"S379","article-title":"Perinatal hypoxic-ischemic damage: Review of the current treatment possibilities","volume":"69","author":"Frajewicki","year":"2020","journal-title":"Physiol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"631258","DOI":"10.3389\/fped.2021.631258","article-title":"Pathophysiology of cerebral hyperperfusion in term neonates with hypoxic-ischemic encephalopathy: A systematic review for future research","volume":"9","author":"Kleuskens","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Martini, S., Castellini, L., Parladori, R., Paoletti, V., Aceti, A., and Corvaglia, L. (2021). Free radicals and neonatal brain injury: From underlying pathophysiology to antioxidant treatment perspectives. Antioxidants, 10.","DOI":"10.3390\/antiox10122012"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mota-Rojas, D., Villanueva-Garc\u00eda, D., Solimano, A., Muns, R., Ibarra-R\u00edos, D., and Mota-Reyes, A. (2022). Pathophysiology of perinatal asphyxia in humans and animal models. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020347"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0300-9572(88)90046-9","article-title":"Early changes in extracellular amino acids and calcium concentrations in rabbit hippocampus following complete 15-min cerebral ischemia","volume":"16","author":"Pluta","year":"1988","journal-title":"Resuscitation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2019.02.025","article-title":"Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS","volume":"142","author":"Albrecht","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ar.21018","article-title":"Alzheimer\u2019s mechanisms in ischemic brain degeneration","volume":"292","author":"Pluta","year":"2009","journal-title":"Anat. Rec."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1203\/00006450-199412000-00003","article-title":"Delayed (\u201csecondary\u201d) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: Continuous 48-hour studies by phosphorus magnetic resonance spectroscopy","volume":"36","author":"Lorek","year":"1994","journal-title":"Pediatr. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","article-title":"Hypoxic-ischemic encephalopathy: A review for the clinician","volume":"169","author":"Weiss","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.22670","article-title":"Cell therapy for neonatal hypoxia-ischemia and cerebral palsy","volume":"71","author":"Bennet","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pluta, R., Ki\u015b, J., Januszewski, S., Jab\u0142o\u0144ski, M., and Czuczwar, S.J. (2022). Cross-talk between amyloid, tau protein and free radicals in post-ischemic brain neurodegeneration in the form of Alzheimer\u2019s disease proteinopathy. Antioxidants, 11.","DOI":"10.3390\/antiox11010146"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41390-019-0639-6","article-title":"Free radicals and neonatal encephalopathy: Mechanisms of injury, biomarkers, and antioxidant treatment perspectives","volume":"87","author":"Martini","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2012.06.012","article-title":"Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer\u2019s disease neuropathology in APPSwe\/PS1A246E transgenic mice","volume":"34","author":"Zhang","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/hipo.22965","article-title":"Delayed injury of hippocampal interneurons after neonatal hypoxia-ischemia and therapeutic hypothermia in a murine model","volume":"28","author":"Emerson","year":"2018","journal-title":"Hippocampus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0271678X20942707","article-title":"Accumulation of PSA-NCAM marks nascent neurodegeneration in the dorsal hippocampus after neonatal hypoxic-ischemic brain injury in mice","volume":"41","author":"Lechner","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_45","unstructured":"Pluta, R. (2021). Cerebral Ischemia, Exon Publications."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tarkowska, A., Furmaga-Jab\u0142o\u0144ska, W., Bogucki, J., Kocki, J., and Pluta, R. (2021). Alzheimer\u2019s disease associated presenilin 1 and 2 genes dysregulation in neonatal lymphocytes following perinatal asphyxia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105140"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ther.2020.0016","article-title":"Total tau protein as investigated by cerebral microdialysis increases in hypothermic cardiac arrest: A Pig Study","volume":"11","author":"Schiefecker","year":"2021","journal-title":"Ther. Hypothermia Temp. Manag."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.braindev.2013.10.007","article-title":"Serum tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia","volume":"36","author":"Takahashi","year":"2014","journal-title":"Brain Dev."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tarkowska, A., Furmaga-Jab\u0142o\u0144ska, W., Bogucki, J., Kocki, J., and Pluta, R. (2022). Hypothermia after perinatal asphyxia does not affect genes responsible for amyloid production in neonatal peripheral lymphocytes. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123263"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Benterud, T., Pankratov, L., Solberg, R., Bolstad, N., Skinningsrud, A., Baumbusch, L., Sandvik, L., and Saugstad, O.D. (2015). Perinatal asphyxia may influence the level of beta-amyloid (1-42) in cerebrospinal fluid: An experimental study on newborn pigs. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140966"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2008.03.027","article-title":"Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"31","author":"Hansson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nair, J., and Kumar, V.H.S. (2018). Current and emerging therapies in the management of hypoxic ischemic encephalopathy in Neonates. Children, 5.","DOI":"10.3390\/children5070099"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22368","DOI":"10.3390\/ijms160922368","article-title":"Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy","volume":"16","author":"Dixon","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.drudis.2015.09.001","article-title":"agents for neonatal hypoxic-ischemic brain injury","volume":"20","author":"Wu","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0095-5108(02)00059-3","article-title":"Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: Current concepts","volume":"29","author":"Grow","year":"2002","journal-title":"Clin. Perinatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"30128","DOI":"10.1074\/jbc.M202931200","article-title":"Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury","volume":"277","author":"Han","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainresrev.2005.07.003","article-title":"Apoptosis in perinatal hypoxic-ischemic brain injury: How important is it and should it be inhibited?","volume":"50","author":"Northington","year":"2005","journal-title":"Brain Res. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.nbd.2005.07.015","article-title":"TAT-mediated delivery of Bcl-XL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF","volume":"21","author":"Yin","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fendo.2019.00480","article-title":"Melatonin: Clinical perspectives in neurodegeneration","volume":"10","author":"Cardinali","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.3390\/ijms14059379","article-title":"Neuroprotective effect of melatonin: A novel therapy against perinatal hypoxia-ischemia","volume":"14","author":"Arteaga","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Arteaga, O., \u00c1lvarez, A., Revuelta, M., Santaolalla, F., Urtasun, A., and Hilario, E. (2017). Role of antioxidants in neonatal hypoxic\u2013ischemic brain injury: New therapeutic approaches. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020265"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","article-title":"Melatonin: Pharmacology, functions and therapeutic benefits","volume":"15","author":"Tordjman","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","article-title":"Neonatal hypoxic ischemic encephalopathy: An update on disease pathogenesis and treatment","volume":"17","author":"Ekici","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jez.1400230108","article-title":"Evidences associating pineal gland function with alterations in pigmentation","volume":"23","author":"McCord","year":"1917","journal-title":"J. Exp. Zool."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, the pineal gland factor that lightens melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-3940(81)90120-8","article-title":"Pineal, retinal and Harderian gland melatonin in a diurnal species, the Richrdson\u2019s ground squirrel (Spermophilus richardsonii)","volume":"22","author":"Reiter","year":"1981","journal-title":"Neurosci. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(93)90160-S","article-title":"Circadian clock functions localized in xenopus retinal photoreceptors","volume":"10","author":"Cahill","year":"1993","journal-title":"Neuron"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0024-3205(97)00234-8","article-title":"Evidence for tryptophan hydroxylase and hydroxyindol-O-methyl-transferase mRNAs in human blood platelets","volume":"60","author":"Champier","year":"1997","journal-title":"Life Sci."},{"key":"ref_70","first-page":"453","article-title":"Melatonin and the gastrointestinal system","volume":"53","author":"Martin","year":"1998","journal-title":"Therapy"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-079X.2000.280401.x","article-title":"Evidence for melatonin synthesis in mouse and human bone marrow cells","volume":"28","author":"Conti","year":"2000","journal-title":"J. Pineal Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1023\/A:1020107915919","article-title":"Gastrointestinal melatonin: Localization, function, and clinical relevance","volume":"47","author":"Bubenik","year":"2002","journal-title":"Dig Dis. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1096\/fj.03-0694fje","article-title":"Evidence of melatonin synthesis by human lymphocytes and its physiological significance: Possible role as intracrine, autocrine, and\/or paracrine substance","volume":"18","author":"Calvo","year":"2004","journal-title":"FASEB J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/ENDO:27:2:137","article-title":"On the role of melatonin in skin physiology and pathology","volume":"27","author":"Slominski","year":"2005","journal-title":"Endocrine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.04-2079rev","article-title":"The cutaneous serotoninergic\/melatoninergic system securing a place under the sun","volume":"19","author":"Slominski","year":"2005","journal-title":"FASEB J."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tan, D., Xu, B., Zhou, X., and Reiter, R. (2018). Pineal calcifcation, melatonin production, aging, associated health consequences and rejuvenation of the pineal gland. Molecules, 23.","DOI":"10.3390\/molecules23020301"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"44","DOI":"10.32794\/mr11250011","article-title":"Mitochondria: The birth place, battle ground and the site of melatonin metabolism in cells","volume":"2","author":"Tan","year":"2019","journal-title":"Melatonin Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.131.3409.1312","article-title":"Enzymatic O-methylation of N-Acetylserotonin to melatonin","volume":"131","author":"Axelrod","year":"1960","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-3002(60)90453-4","article-title":"Biosynthesis of melatonin: Enzymic conversion of serotonin to N-acetylserotonin","volume":"43","author":"Weissbach","year":"1960","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1126\/science.270.5242.1681","article-title":"Pineal serotonin N-acetyltransferase: Expression cloning and molecular analysis","volume":"270","author":"Coon","year":"1995","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/pr.55.2.2","article-title":"Generation of the melatonin endocrine message in mammals: A review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters","volume":"55","author":"Simonneaux","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"ref_82","first-page":"311","article-title":"Origin of cerebrospinal fuid melatonin and possible function in the integration of photoperiod","volume":"61","author":"Tricoire","year":"2003","journal-title":"Reprod. (Camb. Engl.) Suppl."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/0748730404267340","article-title":"Theory of the origin of the pineal gland\u2014A tale of conflict and resolution","volume":"19","author":"Klein","year":"2004","journal-title":"J. Biol. Rhythms."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.1993.tb00478.x","article-title":"The immunoneuroendocrine role of melatonin","volume":"14","author":"Maestroni","year":"1993","journal-title":"J. Pineal Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","article-title":"Melatonin: Physiological effects in humans","volume":"61","author":"Claustrat","year":"2015","journal-title":"Neurochirurgie"},{"key":"ref_86","first-page":"57","article-title":"Melatonin: A potent endogenous hydroxyl radical scavenger","volume":"1","author":"Tan","year":"1993","journal-title":"Endocr. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000014635","article-title":"Signifcance of melatonin in antioxidative defense system: Reactions and products","volume":"9","author":"Tan","year":"2000","journal-title":"Neurosignals"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1034\/j.1600-079X.2003.02111.x","article-title":"Melatonin: A hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin","volume":"34","author":"Tan","year":"2003","journal-title":"J. Pineal Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0065-1281(76)80092-X","article-title":"Melatonin and enterochromaffin cells","volume":"55","author":"Raikhlin","year":"1976","journal-title":"Acta Histochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1210\/endo-102-2-582","article-title":"Transport of maternal melatonin to suckling rats and the fate of melatonin in the neonatal rats","volume":"102","author":"Reppert","year":"1978","journal-title":"Endocrinology"},{"key":"ref_91","first-page":"838","article-title":"Melatonin rhythm in human milk","volume":"77","author":"Illnerova","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-079X.2005.00261.x","article-title":"Melatonin as an antioxidant: Physiology versus pharmacology","volume":"39","author":"Reiter","year":"2005","journal-title":"J. Pineal Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"NP105","DOI":"10.1177\/0890334415625217","article-title":"Melatonin concentrations and antioxidative capacity of human breast milk according to gestational age and the time of the day","volume":"32","author":"Katzer","year":"2016","journal-title":"J. Hum. Lact."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jpi.12066","article-title":"Melatonin synthesis in human colostrum mononuclear cells enhances dectin-1-mediated phagocytosis by mononuclear cells","volume":"55","author":"Tamura","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_95","first-page":"643","article-title":"La m\u00e9latonine: Hormone et m\u00e9dicament","volume":"192","author":"Touitou","year":"1998","journal-title":"C. R. Soc. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM199701163360306","article-title":"Melatonin in humans","volume":"336","author":"Brzezinski","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_97","first-page":"19","article-title":"Melatonin in humans","volume":"57","author":"Karasek","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_98","first-page":"185","article-title":"Sleep and melatonin in infants: A preliminary study","volume":"20","author":"Sadeh","year":"1997","journal-title":"Sleep"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"F50","DOI":"10.1136\/archdischild-2014-306104","article-title":"Getting rhythm: How do babies do it?","volume":"100","author":"Joseph","year":"2014","journal-title":"Arch. Dis. Child. Fetal Neonatal. Ed."},{"key":"ref_100","first-page":"899","article-title":"Melatonin: A sleep promoting hormone","volume":"20","author":"Zhdanova","year":"1997","journal-title":"Sleep"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(84)90412-4","article-title":"Fall in nocturnal serum melatonin during prepuberty and pubescence","volume":"1","author":"Waldhauser","year":"1984","journal-title":"Lancet"},{"key":"ref_102","first-page":"1","article-title":"Trends in the use of complementary health approaches among adults: United States, 2002\u20132012","volume":"79","author":"Clarke","year":"2015","journal-title":"Natl. Health Stat. Rep."},{"key":"ref_103","first-page":"1","article-title":"Use of complementary health approaches among children aged 4\u201317 years in the United States: National Health Interview Survey, 2007\u20132012","volume":"78","author":"Black","year":"2015","journal-title":"Natl. Health Stat. Rep."},{"key":"ref_104","first-page":"327","article-title":"Should melatonin be used as a sleeping aid for elderly people?","volume":"72","author":"Pro","year":"2019","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_105","first-page":"548","article-title":"Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-elease formulation (Circadin\u00ae) in insomnia","volume":"44","author":"Claustrat","year":"2018","journal-title":"Encephale"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/CLEP.S31624","article-title":"Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: A nationwide prescription database study","volume":"4","author":"Steffenak","year":"2012","journal-title":"Clin. Epidemiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/1403494812464446","article-title":"Hypnotic drug use among 0\u201317 year olds during 2004\u20132011: A nation-wide prescription database study","volume":"40","author":"Hartz","year":"2012","journal-title":"Scand. J. Public Health."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00787-020-01598-1","article-title":"Pediatric use of prescribed melatonin in Sweden 2006\u20132017: A register based study","volume":"30","author":"Hartz","year":"2021","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1600-079X.2002.20920.x","article-title":"On the in vitro antioxidative properties of melatonin","volume":"33","author":"Gulcin","year":"2002","journal-title":"J. Pineal Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s007020050018","article-title":"An assessment of the antioxidant and the antiamyloidogenic properties o melatonin: Implications for Alzheimer\u2019s disease","volume":"107","author":"Pappolla","year":"2000","journal-title":"J. Neural. Transm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"110887","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: A potential therapeutic molecule for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004647-199905000-00005","article-title":"Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia","volume":"19","author":"Kilic","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02253360","article-title":"Actions of melatonin in the reduction of oxidative stress. A review","volume":"7","author":"Reiter","year":"2000","journal-title":"J. Biomed. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.niox.2016.12.001","article-title":"Melatonin influences NO\/NOS pathway and reduces oxidative and nitrosative stress in a model of hypoxic-ischemic brain damage","volume":"62","author":"Blanco","year":"2017","journal-title":"Nitric Oxide"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1203\/01.pdr.0000252546.20451.1a","article-title":"Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion","volume":"61","author":"Welin","year":"2007","journal-title":"Pediatr. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-079X.2008.00639.x","article-title":"Free iron, total F2-isoprostanes and total F4-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: Neuroprotective effect of melatonin","volume":"46","author":"Signorini","year":"2009","journal-title":"J. Pineal Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-079X.2009.00740.x","article-title":"Melatonin protects periventricular white matter from damage due to hypoxia","volume":"48","author":"Kaur","year":"2010","journal-title":"J. Pineal Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/aws285","article-title":"Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model","volume":"136","author":"Robertson","year":"2013","journal-title":"Brain"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/14767058.2012.663232","article-title":"The use of melatonin in hypoxic-ischemic brain damage: An experimental study","volume":"25","author":"Balduini","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1111\/jpi.12443","article-title":"Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor","volume":"64","author":"Sinha","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e12434","DOI":"10.1111\/jpi.12434","article-title":"Rapid modulation of the silent information regulator 1 by melatonin after hypoxia-ischemia in the neonatal rat brain","volume":"63","author":"Carloni","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000320643","article-title":"Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model","volume":"99","author":"Cetinkaya","year":"2011","journal-title":"Neonatology"},{"key":"ref_123","first-page":"435","article-title":"Neuroprotective effects of melatonin administered alone or in combination with topiramate in neonatal hypoxic-ischemic rat model","volume":"30","author":"Ozyener","year":"2012","journal-title":"Restor. Neurol. Neurosci."},{"key":"ref_124","first-page":"771","article-title":"Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia","volume":"27","author":"Alvarez","year":"2012","journal-title":"Histol. Histopathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2016.11.050","article-title":"Melatonin reduces hypoxic-ischaemic (HI) induced autophagy and apoptosis: An in vivo and in vitro investigation in experimental models of neonatal HI brain injury","volume":"653","author":"Hu","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"31638","DOI":"10.18632\/oncotarget.15780","article-title":"Melatonin protects against blood-brain barrier damage by inhibiting the TLR4\/NF-kappaB signaling pathway after LPS treatment in neonatal rats","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"598788","DOI":"10.3389\/fendo.2021.598788","article-title":"Effects of melatonin on neurobehavior and cognition in a cerebral palsy model of plppr5-\/-mice","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000085993","article-title":"Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion","volume":"27","author":"Miller","year":"2005","journal-title":"Dev. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jpi.12156","article-title":"Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia","volume":"57","author":"Carloni","year":"2014","journal-title":"J. Pineal Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jnc.13420","article-title":"No improvement of neuronal metabolism in the reperfusion phase with melatonin treatment after hypoxic-ischemic brain injury in the neonatal rat","volume":"136","author":"Berger","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Berger, H.R., Nyman, A.K.G., Morken, T.S., and Wider\u00f8e, M. (2019). Transient effect of melatonin treatment after neonatal hypoxic-ischemic brain injury in rats. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225788"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e12744","DOI":"10.1111\/jpi.12744","article-title":"Melatonin augments the neuroprotective effects of hypothermia in lambs following perinatal asphyxia","volume":"71","author":"Aridas","year":"2021","journal-title":"J. Pineal Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/acn3.51559","article-title":"Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia","volume":"9","author":"Pang","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nbd.2018.10.004","article-title":"Melatonin as an adjunct to therapeutic hypothermia in a piglet model of neonatal encephalopathy: A translational study","volume":"121","author":"Robertson","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/s41598-020-60858-x","article-title":"High-dose melatonin and ethanol excipient combined with therapeutic hypothermia in a newborn piglet asphyxia model","volume":"10","author":"Robertson","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1600-079X.2001.310409.x","article-title":"Increased levels of malondialdehyde and nitrite\/nitrate in the blood of asphyxiated newborns: Reduction by melatonin","volume":"31","author":"Fulia","year":"2001","journal-title":"J. Pineal Res."},{"key":"ref_137","first-page":"1233","article-title":"Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: A randomized control trial","volume":"68","author":"Ahmad","year":"2018","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/PCC.0000000000002346","article-title":"Hypothermia plus melatonin in asphyctic newborns: A randomized-controlled pilot study","volume":"21","year":"2020","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/NPM-181830","article-title":"A randomized controlled trial on the use of magnesium sulfate and melatonin in neonatal hypoxic ischemic encephalopathy","volume":"12","author":"Soliman","year":"2020","journal-title":"J. Neonatal Perinat. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpn.2021.02.003","article-title":"Melatonin for neuroprotection in neonatal encephalopathy: A systematic review & meta-analysis of clinical trials","volume":"31","author":"Ahmed","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Roy, J., Tsui, K.C., Ng, J., Fung, M.-L., and Lim, L.W. (2021). Regulation of melatonin and neurotransmission in Alzheimer\u2019s disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136841"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-079X.2009.00692.x","article-title":"Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease","volume":"47","author":"Olcese","year":"2009","journal-title":"J. Pineal Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-015-0027-6","article-title":"Prophylactic melatonin significantly reduces Alzheimer\u2019s neuropathology and associated cognitive deficits independent of antioxidant pathways in A\u03b2PPswe\/PS1 mice","volume":"10","author":"Delic","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1471-4159.2003.01654.x","article-title":"Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer\u2019s disease","volume":"85","author":"Matsubara","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1745-7254.2005.00102.x","article-title":"Effects of melatonin on wortmannin-induced tau hyperphosphorylation","volume":"26","author":"Deng","year":"2005","journal-title":"Acta Pharm. Sin."},{"key":"ref_146","first-page":"1124.e13","article-title":"Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse","volume":"33","author":"Venegas","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jphp.12830","article-title":"Melatonin ameliorates A\u03b21-42-induced Alzheimer\u2019s cognitive deficits in mouse model","volume":"70","author":"Gong","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejphar.2010.04.041","article-title":"Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain","volume":"640","author":"Tyagi","year":"2010","journal-title":"Eur. J. Pharm."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-079X.2004.00144.x","article-title":"Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer\u2019s disease","volume":"37","author":"Feng","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"113100","DOI":"10.1016\/j.bbr.2020.113100","article-title":"Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer\u2019s disease","volume":"402","author":"Labban","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3233\/JAD-171178","article-title":"Melatonin in synaptic impairments of Alzheimer\u2019s disease","volume":"63","author":"Shi","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: A systematic review","volume":"71","author":"Andersen","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Vasey, C., McBride, J., and Penta, K. (2021). Circadian rhythm dysregulation and restoration: The role of melatonin. Nutrients, 13.","DOI":"10.3390\/nu13103480"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-079X.1997.tb00302.x","article-title":"Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications","volume":"22","author":"Yeleswaram","year":"1997","journal-title":"J. Pineal Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cen.13993","article-title":"Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study","volume":"91","author":"Mistraletti","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Salehi, B., Sharopov, F., Fokou, P.V.T., Kobylinska, A., Jonge, L., Tadio, K., Sharifi-Rad, J., Posmyk, M.M., Martorell, M., and Martins, N. (2019). Melatonin in medicinal and food plants: Occurrence, bioavailability, and health potential for humans. Cells, 8.","DOI":"10.3390\/cells8070681"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2020.05.003","article-title":"In vitro and in vivo evaluation of organic solvent-free injectable melatonin nanoformulations","volume":"152","author":"Molska","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/3\/1105\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:13:19Z","timestamp":1760119999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/3\/1105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,22]]},"references-count":158,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["molecules28031105"],"URL":"https:\/\/doi.org\/10.3390\/molecules28031105","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,22]]}}}